Unknown NA INTERVENTIONAL 2-arm NCT06124703

Different Dosing Regimens of STOP-AST

Comparing Two Dosing Regimens of the Efficacy of Short-term Oral Prednisone Therapy on Acute Subjective Tinnitus

Sponsor: Eye & ENT Hospital of Fudan University

Conditions Hearing Loss Sensorineural Hearing Loss Tinnitus

Interventions Ginkgo Biloba Extract Prednisone tablet

Updated 4 times since 2023 Last updated: Nov 8, 2023 Started: Nov 10, 2023 Primary completion: Feb 10, 2024 Completion: Nov 30, 2024

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Listed as NCT06124703, this NA trial focuses on Hearing Loss and Sensorineural Hearing Loss and remains ongoing. Sponsored by Eye & ENT Hospital of Fudan University, it has been updated 4 times since 2023, reflecting limited change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.

Status Flow

Change History

4 versions recorded

Jan 2026 — Present [monthly]

Unknown NA

Status: Not Yet Recruiting → Unknown
Sep 2024 — Jan 2026 [monthly]

Not Yet Recruiting NA
Jul 2024 — Sep 2024 [monthly]

Not Yet Recruiting NA
Dec 2023 — Jul 2024 [monthly]

Not Yet Recruiting NA

First recorded

Nov 2023

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Eye & ENT Hospital of Fudan University

Data source: Eye & ENT Hospital of Fudan University

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

No location information available.